Predictive value of combined detection of prothrombin time-international normalized ratio-to-albumin ratio, model for end-stage liver disease-Na and high-density lipoproteincholesterol in prognosis of patients with acute-on-chronic liver failure

WANG Juan; ZHANG Ying; LIU Xianjin; ZHU Xiaohong

doi:10.7619/jcmp.20232422

Journal of Clinical Medicine in Practice > 2023 > 27(19): 94-100. > DOI: 10.7619/jcmp.20232422

WANG Juan, ZHANG Ying, LIU Xianjin, ZHU Xiaohong. Predictive value of combined detection of prothrombin time-international normalized ratio-to-albumin ratio, model for end-stage liver disease-Na and high-density lipoproteincholesterol in prognosis of patients with acute-on-chronic liver failure[J]. Journal of Clinical Medicine in Practice, 2023, 27(19): 94-100. DOI: 10.7619/jcmp.20232422

Citation:

PDF (1303 KB)

Predictive value of combined detection of prothrombin time-international normalized ratio-to-albumin ratio, model for end-stage liver disease-Na and high-density lipoproteincholesterol in prognosis of patients with acute-on-chronic liver failure

Department of Infectious Disease, the Third People's Hospital of Nantong in Jiangsu Province, Nantong Third Hospital Affiliated to Nantong University, Nantong, Jiangsu, 226006

More Information

Received Date: July 30, 2023
Revised Date: September 26, 2023
Available Online: October 18, 2023

Graphical Abstract

Abstract

Abstract

Objective
To explore the predictive value of combined detection of prothrombin time-international normalized ratio-to-albumin ratio(PTAR), model for end-stage liver disease-Na (MELD-Na) and high-density lipoproteincholesterol(HDL-C) in prognosis of patients with acute-on-chronic liver failure (ACLF).
Methods
The clinical data of 154 patients with ACLF were retrospectively analyzed and divided into survival group (95 cases) and death group (59 cases) according to the prognosis on the 90th day after diagnosis. The clinical baseline indexes at admission were compared between the two groups. The correlations among PTAR, HDL-C and MELD-Na were analyzed. The prognostic factors of ACLF patients were analyzed. Receiver operating characteristic (ROC) curves of PTAR, HDL-C, MELD-Na and their combination prediction(PTAR+MELD-Na+HDL-C) models were drawn to evaluate their prognostic efficacy in ACLF patients. According to the truncation value (0.530) of the combined model, patients were divided into group A (< 0.530, n=47) and group B (≥0.530, n=107). The survival rates of the two groups were compared by Kaplan-Meier curve analysis.
Results
There were significant differences in age, total bilirubin (TBil), albumin (ALB), creatinine (Cr), prothrombin time (PT), serum sodium (Na+), white blood cell (WBC), platelet (PLT), PTAR, HDL-C and MELD-Na between two groups (P < 0.05). PTAR was positively correlated with MELD-Na (r=0.407, P < 0.001); PTAR and MELD-Na were negatively correlated with HDL-C (r=-0.316, -0303, P < 0.001). Age, TBil, PT, PTAR and MELD-Na were independent influencing factors for the prognosis of ACLF patients (P < 0.05), and HDL-C was an effective predictor of the prognosis of ACLF patients. The area under curves (AUC) of PTAR, HDL-C and MELD-Na were 0.722, 0.717 and 0.738, respectively; the AUC of the combined prediction model was 0.801(95%CI, 0.722 to 0.881, P < 0.001), the sensitivity was 0.627, the specificity was 0.916, the Jorden index was 0.543, and the cutoff value was 0.530. Kaplan-Meier curve analysis showed that the cumulative survival rate in the group A was significantly higher than that in the group B (P < 0.001).
Conclusion
PTAR, HDL-C and MELD-Na are all independent influencing factors for the short-term prognosis of ACLF patients, and the combined prediction model of the above three factors has a good prognostic value for ACLF patients.

FullText(HTML)

References (31)

References

[1]	中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2012年版)[J]. 实用肝脏病杂志, 2013, 16(3): 210-216. https://www.cnki.com.cn/Article/CJFDTOTAL-GBSY201303006.htm
[2]	张静, 周新民. 5种评分系统对慢加急性肝衰竭患者短期病死率的预测价值[J]. 临床肝胆病杂志, 2019, 35(9): 1990-1994. https://www.cnki.com.cn/Article/CJFDTOTAL-LCGD201909024.htm
[3]	丁蕊, 赵红, 王琦, 等. 低三碘甲腺原氨酸综合征对慢加急性肝衰竭患者短期预后的预测价值[J]. 中国肝脏病杂志: 电子版, 2018, 10(4): 90-95. https://www.cnki.com.cn/Article/CJFDTOTAL-GZBZ201804022.htm
[4]	姚雅极, 邹圣强, 胡佳民, 等. 老年肝衰竭患者预后影响因素分析及其预测模型的构建[J]. 江苏大学学报: 医学版, 2021, 31(2): 143-146, 151. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJYZ202102011.htm
[5]	LONGHEVAL G, VEREERSTRAETEN P, THIRY P, et al. Predictive models of short- and long-term survival in patients with nonbiliary cirrhosis[J]. Liver Transplant, 2003, 9(3): 260-267. doi: 10.1053/jlts.2003.50049
[6]	MANKA P, OLLIGES V, BECHMANN L P, et al. Low levels of blood lipids are associated with etiology and lethal outcome in acute liver failure[J]. PLoS One, 2014, 9(7): e102351. doi: 10.1371/journal.pone.0102351
[7]	MALINCHOC M, KAMATH P S, GORDON F D, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology, 2000, 31(4): 864-871. doi: 10.1053/he.2000.5852
[8]	KONDO T, MACDONALD S, ENGELMANN C, et al. The role of RIPK1 mediated cell death in acute on chronic liver failure[J]. Cell Death Dis, 2021, 13(1): 5. doi: 10.1038/s41419-021-04442-9
[9]	姚运海, 赵卫峰, 甘建和. 终末期肝病模型联合动脉血乳酸对乙型肝炎病毒相关慢加急性肝衰竭预后的评价: 97例患者的回顾性分析[J]. 中华肝脏病杂志, 2019(4): 256-260. https://www.cnki.com.cn/Article/CJFDTOTAL-LCPF202211001.htm
[10]	BAJAJ J S, O'LEARY J G, LAI J C, et al. Acute-on-chronic liver failure clinical guidelines[J]. Am J Gastroenterol, 2022, 117(2): 225-252. doi: 10.14309/ajg.0000000000001595
[11]	吕建林, 毛德文, 柳琳琳, 等. 中西医结合治疗慢加急性肝衰竭的临床研究进展[J]. 中西医结合肝病杂志, 2021, 31(11): 1047-1050. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXGB202111027.htm
[12]	HARUKI K, SHIBA H, SAITO N, et al. Risk stratification using a novel liver functional reserve score of combination prothrombin time-international normalized ratio to albumin ratio and albumin in patients with hepatocellular carcinoma[J]. Surgery, 2018, 164(3): 404-410. doi: 10.1016/j.surg.2018.02.022
[13]	GAO F, CAI M X, LIN M T, et al. Prognostic value of international normalized ratio to albumin ratio among critically ill patients with cirrhosis[J]. European Journal of Gastroenterology & Hepatology, 2019, 31(7): 824-831.
[14]	CAI M, HAN Z, HE X, et al. Usefulness of international normalized ratio to albumin ratio for evaluation of mortality in hepatitis B virus-associated decompensated cirrhosis[J]. Biomed Res Int, 2021, 2021: 6664574.
[15]	SREERAJ S. Assessment of INR to albumin ratio in predicting outcome during hospital stay in patients with cirrhosis of liver with Sepsis[J]. J Assoc Physicians India, 2022, 70(4): 11-12.
[16]	徐英, 黄小平, 陈丽, 等. 高密度脂蛋白胆固醇对HBV相关慢加急性肝衰竭严重程度及预后的预测价值[J]. 临床肝胆病杂志, 2021, 37(7): 1632-1635. https://www.cnki.com.cn/Article/CJFDTOTAL-LCGD202107033.htm
[17]	OKADA N, SANADA Y, URAHASHI T, et al. Endotoxin metabolism reflects hepatic functional reserve in end-stage liver disease[J]. Transplant Proc, 2018, 50(5): 1360-1364.
[18]	TRIEB M, RAINER F, STADLBAUER V, et al. HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure[J]. J Hepatol, 2020, 73(1): 113-120.
[19]	HERNAEZ R, KRAMER J R, LIU Y, et al. Prevalence and short-term mortality of acute-on-chronic liver failure: a national cohort study from the USA[J]. J Hepatol, 2019, 70(4): 639-647.
[20]	OIKONOMOU T, GOULIS L, DOUMTSIS P, et al. ALBI and PALBI grades are associated with the outcome of patients with stable decompensated cirrhosis[J]. Ann Hepatol, 2019, 18(1): 126-136.
[21]	LEHMANN J M, CLAUS K, JANSEN C, et al. Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality[J]. Liver Int, 2018, 38(5): 875-884.
[22]	郭金, 龚作炯, 石春霞. 乙型肝炎病毒相关慢加急性肝衰竭合并感染研究进展[J]. 中国肝脏病杂志: 电子版, 2022, 14(3): 5-8. https://www.cnki.com.cn/Article/CJFDTOTAL-GZBZ202203002.htm
[23]	吴蓓, 杜凌遥, 马元吉, 等. 不同组合人工肝支持系统治疗乙型肝炎病毒相关早、中期慢加急性肝衰竭患者的疗效及对炎症指标的影响[J]. 中国肝脏病杂志: 电子版, 2021, 13(1): 32-38. https://www.cnki.com.cn/Article/CJFDTOTAL-GZBZ202101006.htm
[24]	王娟, 章颖, 明芳, 等. NLR、PTAR、MELD评分联合检测对失代偿期乙肝肝硬化患者短期预后的预测价值[J]. 中国临床医学, 2022, 29(6): 950-956. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYX202206010.htm
[25]	FENG R R, GUO X Z, KOU Y, et al. Association of lipid profile with decompensation, liver dysfunction, and mortality in patients with liver cirrhosis[J]. Postgrad Med, 2021, 133(6): 626-638.
[26]	GAO B, XIAO J Q, ZHANG M, et al. High-density lipoprotein cholesterol for the prediction of mortality in cirrhosis with portal vein thrombosis: a retrospective study[J]. Lipids Health Dis, 2019, 18(1): 79.
[27]	KAMATH P S, WIESNER R H, MALINCHOC M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33(2): 464-470.
[28]	BIGGINS S W, KIM W R, TERRAULT N A, et al. Evidence-based incorporation of serum sodium concentration into MELD[J]. Gastroenterology, 2006, 130(6): 1652-1660.
[29]	ZHANG Q K, WANG M L. Value of model for end-stage liver disease-serum sodium scores in predicting complication severity grades after liver transplantation for acute-on-chronic liver failure[J]. Transplant Proc, 2019, 51(3): 833-841.
[30]	ZHOU Q H, HU C Q, SHI Y, et al. Cryptococcosis in patients with liver cirrhosis: death risk factors and predictive value of prognostic models[J]. Hepatobiliary Pancreat Dis Int, 2021, 20(5): 460-468.
[31]	WANG X H, JIANG X M, GAO P X, et al. Risk factors and prognostic analysis of acute-on-chronic liver failure of chronic hepatitis B after cessation of nucleos(t)ide analogs[J]. Eur J Gastroenterol Hepatol, 2020, 32(2): 265-275.

Cited By

Get Citation

PDF

XML

Article views (105) PDF downloads (6)

Turn off MathJax

Article Contents

Abstract

References

Predictive value of combined detection of prothrombin time-international normalized ratio-to-albumin ratio, model for end-stage liver disease-Na and high-density lipoproteincholesterol in prognosis of patients with acute-on-chronic liver failure

Abstract

References

Catalog

Export File

Citation

Format

Content